The IGF-1R inhibitor BMS-754807, PI3K/mTOR inhibitor PF-04691502 and mTOR inhibitor AZD8055 were the most effective in CP CML patient samples. Here, IGF1R is linked to chronic myelogenous leukemia, BCR-ABL1 positive.